These guidelines were developed
jointly by the American Society of Health-System Pharmacists (ASHP), the
Infectious Diseases Society of America (IDSA), the Surgical Infection Society
(SIS), and the Society for Healthcare Epidemiology of America (SHEA). This work
represents an update to the previously published ASHP Therapeutic Guidelines on
Antimicrobial Prophylaxis in Surgery, as well as guidelines from IDSA and SIS.
The guidelines are intended to provide practitioners with a standardized
approach to the rational, safe, and effective use of antimicrobial agents for
the prevention of surgical-site infections (SSIs) based on currently available
clinical evidence and emerging issues.
*For information on the timing of
future updates of this guideline, please contact the ASHP.